Teva Pharma Industries Ltd ADR (NYSE: TEVA) is the world's largest generic drug maker, with over 500 generic and biosimilar treatments in its broad portfolio. The medical sector giant also has a line ...

Target has been sued for allegedly concealing the risks of its diversity initiatives, leading to a backlash that caused the ...

Although several companies have cut or scaled back DEI programs, Target's reversal on DEI seemed to draw the greatest outrage ...

January 31, 2025WhiteBlueBlackRedGreenMulticolorColorlessSpecial GuestsCommander DecksLiving EnergyEternal MightMagic: The ...

Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...

We assign Teva a Morningstar Uncertainty Rating of High, which largely reflects our quantitative analysis of the firm, based on the return ranges used by our star rating system, as well as our ...

BofA Securities made adjustments to its financial model for Teva Pharmaceutical Industries Ltd (NYSE:TEVA), resulting in a lowered price target. While the firm maintained a Buy rating on the stock, ...

Ordering a cocktail or a glass of wine (or three) when out to dinner can significantly inflate your bill. Consider getting ...

Discover 10 generic grocery products that consistently outperform name brands in blind taste tests—proof that savings don't ...

Sales of generic brand products hit an all-time high last year as consumers placed more trust in grocery retailers.

Target, which operates nearly 2,000 stores nationwide and employs more than 400,000 people, said it already had planned to end the racial program this year. The company said Friday that it also would ...